[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.191.72. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 784
Citations 0
Correction
July 3, 2013

Clarification of Net Reclassification Improvement

JAMA. 2013;310(1):99. doi:10.1001/jama.2013.8142

In the Original Contribution entitled “Association of Fibrosis With Mortaliy and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy,” published in the March 6, 2013, issue of JAMA (2013;309[9]:896-908. doi:10.1001/jama.2013.1363), the paragraph on risk reclassification should be clarified. In the section entitled “Risk Reclassification,” which appears right before the “Comment” section, the fourth sentence of this section should be “The addition of midwall fibrosis yielded an overall net reclassification improvement of 0.26 (95% CI, 0.11-0.41; P = .001).” A few sentences later, the last sentence of the section should be “The overall net reclassification improvement after adding midwall fibrosis status to the risk model was 0.29 (95% CI, 0.11-0.48; P = .002).” This article has been corrected online.

×